Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
MIRA
Stock Latest News
The Fly
Psychedelic: Enveric, Filament Health report earnings results
1d ago
CMND
ENVB
Premium
The Fly
Mira Pharmaceuticals enrolls first subjects in Phase 1 trial of Ketamir-2
4d ago
MIRA
Premium
The Fly
Mira Pharmaceuticals enrolls first subjects in Ketamir-2 trial
4d ago
MIRA
Premium
The Fly
Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit
12d ago
ME
ALC
Premium
The Fly
Mira Pharmaceuticals signs binding LOI to acquire SKNY Pharmaceuticals
12d ago
MIRA
Premium
The Fly
MIRA Pharmaceuticals in binding LOI to acquire SKNY Pharmaceuticals
12d ago
MIRA
Premium
The Fly
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
22d ago
ATAI
CMND
Premium
The Fly
Mira Pharmaceuticals expands Ketamir-2 development with topical treatment
23d ago
MIRA
Premium
The Fly
Psychedelic: MindMed reports Q4 earnings results
29d ago
ATAI
CMND
Premium
The Fly
Mira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trial
1M ago
MIRA
Premium
The Fly
Rising High: Exclusive talk with pharmaceutical development company MIRA
3M ago
ACB
CGC
Premium
The Fly
MIRA Pharmaceuticals submits IND to FDA for Ketamir-2
4M ago
MIRA
Premium
Company Announcements
MIRA Pharmaceuticals Appoints New Board Member and Chairman
4M ago
8K
MIRA
Premium
The Fly
Mira Pharmaceuticals announces preclinical data on Ketamir-2
5M ago
MIRA
Premium
The Fly
MIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatments
6M ago
MIRA
Premium
The Fly
Mira Pharmaceuticals initiated with a Buy at Rodman & Renshaw
6M ago
MIRA
Premium
The Fly
Mira Pharmaceuticals presents preclinical data for Ketamir-2
6M ago
MIRA
Premium
The Fly
Mira Pharmaceuticals advances Ketamir-2 development
7M ago
MIRA
Premium
The Fly
MIRA designates neuropathic pain as primary indication for Ketamir-2
7M ago
MIRA
Premium
The Fly
MIRA says it achieves 100% reversal of neuropathic pain with oral Ketamir-2
7M ago
MIRA
Premium
The Fly
Mira Pharmaceuticals provides update on preparing IND submission
8M ago
MIRA
Premium
The Fly
Mira Pharmaceuticals announces preclinical data on Ketamir-2
8M ago
MIRA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
